PubMed · 8312627
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
S M Aronson. 1993. Virus-speak.. https://pubmed.ncbi.nlm.nih.gov/8312627/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Advances in T cell biology have revealed heterogeneity among T cell populations that is not captured by existing general nomenclature. This issue has caused an ad hoc broadening of core T cell subset definitions and the invention of new subset designations that have not been uniformly delineated. To address this issue, in this Consensus Statement, we propose guidelines that serve three goals. First, they advocate that primary research reports define the experimental basis by which relevant subsets are designated in the methods section of each study. Second, they provide standardized definitions for existing subset designations in popular use, and common experimental criteria for defining each subset are noted. Last, they present an alternative 'modular nomenclature' paradigm. The newly proposed modular nomenclature eschews conceptualization of antigen-experienced T cells as belonging to a few idealized subsets, and the nomenclature instead simply indicates individual biological properties present in a T cell population with brief descriptors. Collectively, these guidelines intend to enhance transparency in the literature while facilitating clearer communication of findings and concepts to researchers, students and clinicians.
With increasing worldwide use of combined vaccines a short and informative system of names or codes for vaccines is essential. In addition, within the EU eleven official languages exist and some more are used. Due to these facts an increasing risk of medication errors for vaccines is emerging. A three-letter code naming system was first developed as part of the Note for guidance on pharmaceutical and biological aspects of combined vaccines (CPMP/BWP/477/97), but was deleted there later. Then a second approach was initiated by the European OMCL Network in order to implement this three-letter code system in the common nomenclature guideline within the Ph. Eur. (Index of standard terms). Both activities have not been successful until now to implement this system. Therefore we now present the three-letter code system in order to initiate either its voluntary use by vaccine manufacturers or to accelerate the obligatory implementation within the EU legislative framework. This coding system is thought to be used in addition to the brand name of the vaccine on the label of the final vaccine container, in order to have a safe last minute check whether the appropriate antigens are given.
Explore the source record for details and available documents.